Sponsor Pipeline

Rakuten Medical, Inc. Clinical Trial Pipeline

Data updated daily from ClinicalTrials.gov — last refresh 2026-08-16
4
Active Trials
1
Recruiting
2
Phase 3
1
Disease Areas
Active Trials by Phase
Phase 3
2
Phase 2
1
Phase 1/2
1
Active Trials
NCT IDTitleConditionStatus
Phase 3
NCT06699212 A Study of ASP-1929 Photoimmunotherapy in Combination With Pembrolizumab in First-line… Recurrent Head and Neck Squamous Cell Carcinoma Recruiting
NCT03769506 ASP-1929 Photoimmunotherapy (PIT) Study in Recurrent Head/Neck Cancer for Patients Who… Head and Neck Cancer Active, Not Recruiting
Phase 2
NCT05182866 ASP-1929 Photoimmunotherapy (PIT) Study in Patients With Recurrent Head/Neck Cancer Head and Neck Cancer Active, Not Recruiting
Phase 1/2
NCT04305795 An Open-label Study Using ASP-1929 Photoimmunotherapy in Combination With Anti-PD1… Recurrent Head and Neck Squamous Cell Carcinoma Active, Not Recruiting
Disease Areas
Head & Neck Cancer (4)
Get alerts when Rakuten Medical, Inc.'s trials change
Status changes, date slips, and new filings — detected daily, delivered to your inbox.
Start monitoring free